Usana Health Sciences (USNA) Liabilities and Shareholders Equity (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Liabilities and Shareholders Equity data on file, last reported at $739.0 million in Q2 2026.

• Liabilities and Shareholders Equity for Q2 2026 came in at $739.0 million, down 1.02% year-over-year; the trailing twelve-month figure through Apr 2026 was $2.9 billion (up 5.2% YoY), and the FY2026 annual result was $742.9 million, down 0.71% from the prior year.
• Liabilities and Shareholders Equity slipped to $739.0 million in Q2 2026 per USNA's latest filing, from $742.9 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $748.2 million in Q4 2024 and troughed at $556.1 million in Q4 2022.
• A 5-year average of $648.5 million and a median of $630.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity dropped 9.85% in 2022, then grew 18.64% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $596.5 million in 2022, then gained by 6.07% to $632.8 million in 2023, then climbed by 18.24% to $748.2 million in 2024, then slipped by 2.89% to $726.6 million in 2025, then increased by 1.7% to $739.0 million in 2026.
• Business Quant data shows USNA's Liabilities and Shareholders Equity at $739.0 million in Q2 2026, $742.9 million in Q1 2026, and $726.6 million in Q3 2025.